T-cell-mediated mucosal immunity in the absence of antibody: lessons from Helicobacter pylori infection

References

• Blaser MJ. Helicobacter pylori: its role in disease. Clin Infect Dis 1992;15:386–91.
   PubMedGoogle Scholar
• Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19:S37–43.
   PubMed Web of Science ®Google Scholar
• Blanchard TG, Czinn SJ. Review article: immunological determinants that may affect the Helicobacter pylori cancer risk. Aliment Pharmacol Ther 1998;12 Suppl 1:83–90.
   PubMedGoogle Scholar
• Correa P, Miller MJS. Carcinogenesis, apoptosis and cell proliferation. Br Med Bull 1998;54:151–62.
   PubMedGoogle Scholar
• Cover TL, Blaser MJ. Helicobacter pylori factors associated with disease. Gastroenterology 1999;117:257–61.
   PubMedGoogle Scholar
• Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999;284:1328–33.
   Google Scholar
• Ernst PB, Gold B. The disease spectrum of H. pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 2000:615–40.
   Google Scholar
• Ley C, Parsonnet J. Helicobacter pylori infection and gastric cancer. Gastroenterology 2001;120:324–5.
   PubMedGoogle Scholar
• Nguyen AM, Engstrand L, Genta RM, Graham DY, el Zaatari FA. Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reaction. J Clin Microbiol 1993; 31:783–7.
   Google Scholar
• Nguyen AM, el Zaatari FA, Graham DY. Helicobacter pylori in the oral cavity. A critical review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;79:705–9.
   PubMedGoogle Scholar
• Megraud F. Transmission of Helicobacter pylori: faecal-oral versus oral-oral route. Aliment Pharmacol Ther 1995;9:Suppl 2:85–91.
   PubMedGoogle Scholar
• Cave DR. Transmission and epidemiology of Helicobacter pylori. Am J Med 1996;100:12S -7S.
   Google Scholar
• Fox JG, Perkins S, Yan L, Shen Z, Attardo L, Pappo J. Local immune response in Helicobacter pylori-infected cats and identifica-tion of H. pylori in saliva, gastric fluid and faeces Immunology 1996;88:400–6.
   Google Scholar
• Song Q Spahr A, Schmid RM, Adler G, Bode G. Helicobacter pylori in the oral cavity: high prevalence and great DNA diversity. Dig Dis Sci 2000;45:2162–7.
   PubMedGoogle Scholar
• Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 1997;113:1983–91.
   PubMed Web of Science ®Google Scholar
• El Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398–402.
   PubMed Web of Science ®Google Scholar
• Kosunen TU, Hurme M, Kovach Z, Rautelin H, Lahdenpohja N, Virtamo J, et al. Interleukin-10 promoter haplotype is associated with increased risk for gastric cancer during Helicobacter pylori infection. Gut 2001;47:A31.
   Google Scholar
• Dunn BE. Pathogenic mechanisms of Helicobacter pylori Gastro-enterol Clin North Am 1993;22:43–57.
   PubMed Web of Science ®Google Scholar
• Dixon MF. Pathophysiology of Helicobacter pylori infection. Scand J Gastroenterol 1994;29:7–10.
   PubMed Web of Science ®Google Scholar
• Crabtree JE, Lindley U. Mucosal interleukin-8 and Helicobacter pylon-associated gastroduodenal disease. Eur J Gastroenterol Hepatol 1994;6 Suppl 1:S33-8:S33–8.
   Google Scholar
• Crowe SE, Alvarez L, Sherman PM, Jin Y, Dytoc M, Hunt RH, et al. Expression of interleukin-8 and CD54 by human gastric epithelium after H. pylori infection in vitro. Gastroenterology 1995;108:65–74.
   PubMed Web of Science ®Google Scholar
• Bliss CM Jr, Golenblock DT, Keates S, Linevsky JK, Kelly CP. Helicobacter pylori lipopolysaccharide binds to CD14 and stimu-lates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes. Infect Immun 1998;66: 5357–63.
   Google Scholar
• Shimoyama T, Everett SM, Dixon MF, Axon AT, Crabtree JE. Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol 1998;51:765–70.
   Google Scholar
• Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K. Tumor necrosis factor a and interferon 7 synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kappaB-like binding sites of the interleukin 8 gene. J Biol Chem 1992;267:22506–11.
   PubMed Web of Science ®Google Scholar
• Fonthan ET, Ruiz B, Perez A, Hunter F, Correa P. Determinants of Helicobacter pylori infection and chronic gastritis. Am J Gastroenterol 1995;90:1094–101.
   PubMedGoogle Scholar
• Appelmelk BJ, Faller G, Claeys D, Kirchner T, Vandenbroucke-Grauls CMJE. Bugs on trial: the case of Helicobacter pylori and autoimmunity. Immunol Today 1998;19:296–9.
   Google Scholar
• Berstad AE, Brandtzaeg P, Stave R, Halstensen TS. Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis. Gut 1997;40:196–203.
   PubMed Web of Science ®Google Scholar
• Yamaoka Y, Kita M, Kodama T, Sawai N, Tanahashi K, Imanishi J. Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 1998;42:609–17.
   PubMed Web of Science ®Google Scholar
• Haeberle H, Kubin M, Bamford KB, Garofalo R, Graham DY, El-Zaateri F, et al. Induction of IL-12 and selection of Thl cells in the gastric mucosa in response to H. pylori. Infect Immun 1997;65: 4229–35.
   Google Scholar
• Hida N, Shimoyama T Jr, Neville P, Dixon MF, Axon AT, Shimoyama T Sr, et al. Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J Clin Pathol 1999;52:658–64.
   PubMed Web of Science ®Google Scholar
• Tomita T, Jackson AM, Hida N, Hayat M, Dixon MF, Shimoyama T, et al. Expression of interleukin-18, a Thl cytokine, in human gastric mucosa is increased in Helicobacter pylori infection. J Infect Dis 2001;183:620–7.
   PubMedGoogle Scholar
• Karttunen R, Karttunen T, Ekre H-PT, MacDonald TT. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 1995;36: 341–5.
   Google Scholar
• D'Elios MM, Manghetti M, Almerigogna F, Amedei A, Costa F, Burroni D, et al. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol 1997;27:1751–5.
   PubMed Web of Science ®Google Scholar
• Bamford KB, Fan XJ, Crowe SE, Leary JF, Gourley WK, Luthra GK, et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998;114:482–92.
   PubMed Web of Science ®Google Scholar
• Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998;66:5964–71.
   PubMed Web of Science ®Google Scholar
• Itoh T, Wakatsuki Y, Yoshida M, Usui T, Matsunaga Y, Kaneko S, et al. The vast majority of gastric T cells are polarized to produce T helper 1 type cytokines upon antigenic stimulation despite the absence of Helicobacter pylori infection. Scand J Gastroenterol 1999;34 Supp1:560–70.
   Google Scholar
• Mattapalli JJ, Dandekar S, Canfield DR, Solnick JV. A predominant Thl type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques Gastroenterology 2000;118:307–15.
   Google Scholar
• Ernst PB, Reyes VE, Gourley WK, Haberle H, Bamford KB. Is the Thl /Th2 lymphocyte balance upset by H. pylori infection? In: Hunt RH, Tytgat GNJ, editors. Helicobacter pylori. Basic mechan-isms to clinical cure 1996. Lancaster: Kluwer Academic Publishers; 1996. p. 150–7.
   Google Scholar
• Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith PD. Helicobacter pylori-induced mucosal inflammation is Thl mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol 2000;165:1022–9.
   PubMed Web of Science ®Google Scholar
• Sommer F, Faller G, Rollinghoff M, Kirchner T, Mak TW, Lohoff M. Lack of gastritis and of an adaptive immune response in interferon regulatory factor- 1 -deficient mice infected with Helicobacter pylori. Eur J Immunol 2001;31:396–402.
   PubMedGoogle Scholar
• Czinn SJ, Cai A, Nedrud JG. Protection of germ-free mice from infection by Helicobacter filis-induced inflammation. Infect Immun 1993;61:637–42.
   Google Scholar
• Thomas JE, Austin S, Dale A, McClean P, Harding M, Coward WA, et al. Protection by human milk IgA against Helicobacter pylori infection in infancy. Lancet 1993;342:121 .
   PubMed Web of Science ®Google Scholar
• Ernst PB, Pappo J. Preventive and therapeutic vaccines against Helicobacter pylori: current status and future challenges. Curr Pharm Res 2000;6:1557–73.
   PubMedGoogle Scholar
• Rappuoli R. Rational design of vaccines. Nat Med 1997;3:374–6.
   PubMedGoogle Scholar
• Sellman S, Blanchard TG, Nedrud JG, Czinn SJ. Vaccine strategies for prevention of Helicobacter pylori infections. Eur J Gastroenterol Hepatol 1995;7:S1–S6.
   Google Scholar
• Sutton P, Lee A. Review Article: Helicobacter pylori vaccines-the current status. Aliment Pharmacol Ther 2000;14:1107–18.
   PubMed Web of Science ®Google Scholar
• Czinn SJ, Nedrud JG. Oral immunization against Helicobacter pylori. Infect Immun 1991;59:2359–63.
   PubMed Web of Science ®Google Scholar
• Chen M, Lee A, Hazen S. Immunisation against gastric helicobacter infection in a mouse/ Helicobacter felis model. Lancet 1992;339:1120–1.
   Google Scholar
• Ferrero RL, Thiberge J-M, Huerre M, Labigne A. Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection. Infect Immun 1994;62:4981–9.
   Google Scholar
• Michetti P, Corthesy-Theulaz I, Davin C, Haas R, Vaney A-C, Heitz M, et al. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 1994;107:1002–11.
   PubMed Web of Science ®Google Scholar
• Pappo J, Thomas WD, Kabok Z, Taylor NS, Murphy JC, Fox JG. Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis. Infect Immun 1995;63:1246–52.
   PubMedGoogle Scholar
• Douce G, Trucotte C, Cropley I, Roberts M, Pizza M, Domenighini M, et al. Mutants of Escherichia coli heat labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci (USA) 1995;92:1644–8.
   PubMed Web of Science ®Google Scholar
• Giuliani MM, Del Giudice G, Giannelli V, Dougan G, Douce G, Rappuoli R, et al. Mucosal adjuvanticity and immunogenidty of LTR72, a novel mutant of Escherichia coli heat-labile enter-otoxin with partial knockout of ADP- ribosyltransferase activity. J Exp Med 1998;187:1123–32.
   PubMed Web of Science ®Google Scholar
• Corthesy-Theulaz I, Porta N, Glauser M, Saraga E, Vaney A-C, et al. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastro-enterology 1995;109:115–21.
   Google Scholar
• Cuenca R, Blanchard TG, Czinn SJ, Nedrud JG, Monath TP, Lee CK, et al. Therapeutic immunization against Helicobacter mustale in naturally infected ferrets. Gastroenterology 1996;110: 1770–5.
   PubMedGoogle Scholar
• Doidge C, Gust I, Lee A, Buck F, Hazell S, Manne U. Therapeutic immunization against Helicobacter pylori infection. Lancet 1994;343:913–4.
   PubMedGoogle Scholar
• Blanchard TG, Czinn SJ, Redline RW, Sigmund N, Harriman G, Nedrud JG. Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice. Cell Immunol 1999;191:74–80.
   PubMed Web of Science ®Google Scholar
• Ermak TH, Giarmasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R, et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 1998;i88:2277–88.
   Google Scholar
• Bogstedt AK, Nava S, Wadstrom T, Hammarstrom L. Helicobacter pylori infections in IgA deficiency: lack of role for the secretory immune system. Chin Exp Immunol 1996;105:202–4.
   PubMed Web of Science ®Google Scholar
• Michetti M, Kelly CP, Kraehenbuhl JP, Bouzourene H, Michetti P. Gastric mucosal alpha (4) beta (7) -integrin-positive CD4 T lymphocytes and immune protection against helicobacter infec-tion in mice. Gastroenterology 2000;119: 109–18.
   Google Scholar
• Pappo J, Torrey D, Castriotta L, Savinainen A, Kabok Z, Ibraghimov A. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect Immun 1999;67:337–41.
   PubMed Web of Science ®Google Scholar
• Mohammadi M, CZ= S, Redline R, Nedrud J. Helicobacter-specific cell-mediated immune responses display a predominant Thl phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J Immunol 1996;156:4729–38.
   Google Scholar
• Saldinger PF, Porta N, Launois P, Louis JA, Waanders GA, Bouzourene H, et al. Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection. Gastroenterology 1998;115:891 —7.
   PubMedGoogle Scholar
• Sawai N, Kita M, Kodama T, Tanahashi T, Yamaoka Y, Tagawa Y, et al. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun 1999;67:279–85.
   PubMed Web of Science ®Google Scholar
• Shirai Y, Wakatsuki Y, Kusumoto T, Nakata M, Yoshida M, Usui T, et al. Induction and maintenance of immune effector cells in the gastric tissue of mice orally immunized to Helicobacter pylori requires salivary glands. Gastroenterology 2000;118:749 — 59.
   PubMedGoogle Scholar
• Yamashita K, Kaneko H, Yamamoto S, Konagaya T, Kusugami K, Mitsuma T. Inhibitory effect of somatostatin on Helicobacter pylori proliferation in vitro. Gastroenterology 1998;115:1123–30.
   PubMed Web of Science ®Google Scholar
• Ogawa T, Kusumoto Y, Hamada S, McGhee JR, Kiyono H. Bacteroides gingivalis-specific serum IgG and IgA subclass anti-bodies in periodontal diseases. Clin Exp Immunol 1990;82:318 — 25.
   Google Scholar
• Valnes K, Brandtzaeg P, Elgjo K, Stave R. Quantitative distribution of immunoglobulin-producing cells in gastric mucosa: relation to chronic gastritis and glandular atrophy. Gut 1986;27:505–14.
   PubMed Web of Science ®Google Scholar
• Halstensen TS, Hvatum M, Scott H, Fausa 0, Brandtzaeg P. Association of subepithelial deposition of activated complement and immunoglobulin G and M response to gluten in celiac disease. Gastroenterology 1992;102:751–9.
   Google Scholar
• MacDermott RP, Nash GS, Bertovich MJ, Seiden MV, Bragdon MJ, Beale MG. Alterations of IgM, IgG, and IgA synthesis and secretion by peripheral blood and intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease. Gastroenterology 1981;81:844–52.
   PubMed Web of Science ®Google Scholar
• Berstad AE, Hogasen K, Bukholm G, Moran AP, Brandtzaeg P. Complement activation directly induced by Helicobacter pylori. Gastroenterology 2001;120:1108 —16.
   Google Scholar
• Brandtzaeg P, Valnes K, Scott H, Rognum TO, Bjerke K, Baldien K. The human gastrointestinal secretory immune system in health and disease. In: Polak JM, Bloom SR, Wright NA, Butler AG, editors. Basic science in gastroenterology: diseases of the gut. Norwich: Page Bros.; 1986. p. 179–200.
   Google Scholar
• Halstensen TS, Mollnes TE, Garred P, Olav F, Brandtzaeg P. Epithelial deposition of immunoglobulin GI and activated complement (C3b and terminal complement complex) in ulcerative colitis. Gastroenterology 1990;98: 1264 —71.
   Google Scholar